MAGNI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 14.559
AS - Asia 10.050
EU - Europa 9.100
SA - Sud America 1.386
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 21
Totale 35.273
Nazione #
US - Stati Uniti d'America 14.218
CN - Cina 5.586
IE - Irlanda 2.243
SG - Singapore 2.226
IT - Italia 1.214
RU - Federazione Russa 1.169
BR - Brasile 1.150
HK - Hong Kong 1.038
DE - Germania 1.019
UA - Ucraina 971
FI - Finlandia 873
VN - Vietnam 481
SE - Svezia 455
GB - Regno Unito 431
FR - Francia 229
CA - Canada 200
IN - India 171
AR - Argentina 107
MX - Messico 105
BE - Belgio 100
JP - Giappone 83
PL - Polonia 82
BD - Bangladesh 65
ZA - Sudafrica 61
NL - Olanda 60
ES - Italia 56
IQ - Iraq 55
AT - Austria 48
IR - Iran 45
EC - Ecuador 44
TR - Turchia 42
CZ - Repubblica Ceca 29
CO - Colombia 26
CH - Svizzera 25
ID - Indonesia 24
PK - Pakistan 23
EU - Europa 22
UZ - Uzbekistan 22
LT - Lituania 21
MA - Marocco 21
SA - Arabia Saudita 18
IL - Israele 16
VE - Venezuela 15
AE - Emirati Arabi Uniti 14
AU - Australia 14
CL - Cile 14
AZ - Azerbaigian 13
KR - Corea 13
MY - Malesia 13
GR - Grecia 12
JO - Giordania 12
RO - Romania 12
PE - Perù 11
DO - Repubblica Dominicana 10
PH - Filippine 10
KZ - Kazakistan 9
AM - Armenia 8
EG - Egitto 8
KE - Kenya 8
LV - Lettonia 8
LK - Sri Lanka 7
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
BG - Bulgaria 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
BB - Barbados 5
BO - Bolivia 5
HU - Ungheria 5
JM - Giamaica 5
LB - Libano 5
QA - Qatar 5
UY - Uruguay 5
AL - Albania 4
BY - Bielorussia 4
DZ - Algeria 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
KW - Kuwait 3
MD - Moldavia 3
MU - Mauritius 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
UG - Uganda 3
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
Totale 35.241
Città #
Dublin 2.239
Chandler 2.067
Dallas 1.447
Jacksonville 1.303
Singapore 1.235
Nanjing 1.147
Ashburn 1.075
San Jose 1.034
Hong Kong 1.018
Beijing 992
Boardman 694
Nanchang 481
Los Angeles 388
Princeton 365
Lawrence 354
Pavia 352
Wilmington 347
New York 327
Ann Arbor 326
Changsha 326
Shenyang 310
Hebei 309
Dearborn 304
Medford 302
Helsinki 291
Shanghai 250
Moscow 248
Jiaxing 245
Munich 218
Milan 203
Tianjin 196
Hangzhou 190
Ho Chi Minh City 179
Buffalo 165
Redondo Beach 163
São Paulo 118
Hanoi 103
Toronto 101
Turku 99
Brussels 95
Woodbridge 86
Tokyo 79
Seattle 77
Norwalk 71
Santa Clara 67
Warsaw 67
Verona 62
Brooklyn 56
Guangzhou 55
Denver 54
Montreal 51
Kunming 49
London 49
Piscataway 49
Falkenstein 45
Orem 45
Mexico City 44
San Francisco 44
Stockholm 44
Jinan 43
Chennai 42
Johannesburg 42
Atlanta 41
Chicago 41
Houston 41
Boston 40
Nuremberg 40
Rome 40
Frankfurt am Main 38
Florence 37
Ningbo 34
Phoenix 34
Poplar 34
Zhengzhou 34
Fairfield 32
Rio de Janeiro 28
Des Moines 26
Washington 26
Hefei 25
Vienna 25
Brasília 24
Amsterdam 22
Manchester 21
Tashkent 21
Haiphong 20
Mumbai 20
Taizhou 20
Zurich 20
Belo Horizonte 19
Auburn Hills 18
Biên Hòa 18
Brescia 18
Curitiba 18
Dhaka 18
Querétaro 18
Ankara 17
Baghdad 17
Berlin 17
Charlotte 17
Turin 17
Totale 23.823
Nome #
An automatic implementation of ACMG/ClinGen guidelines for constitutional Copy Number Variants annotation and interpretation 187
A comparison of eVai, CADD and VVP variant prediction results on the ICR639 hereditary cancer dataset 180
Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management 165
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 163
Quantitative evaluation of RC-106 antitumor activity in GBM spheroids through tumor growth inhibition modeling based on cell counts data 159
A novel method for proteomic analysis of immunoglobulin light chains and attribution to a germline gene-based family 151
A Markov decision process: screening hereditary hemochromatosis 150
A Bayesian approach to non-parametric AUC estimation in population studies 150
A Bayesian method for clustering gene expression temporal profiles from microarray data 148
Living Materials for the Detection of Volatile Compounds to Monitor Agroindustrial Processes 146
Astrazioni temporali per il clustering di profili di espressione genica 144
Phenotypes extraction from clinical descriptions using Large Language Models 142
A non parametric population approach for selecting biomarkers of a drug action 141
An integrative pathology workflow to enhance molecular diagnostics in precision oncology 138
DIVAs: a phenotype-based machine-learning model to assess the pathogenicity of digenic variant combinations 138
Clinical classification of myelofibrosis with myeloid metaplasia (MMM): cluster analysis of 861 patients enrolled into a nationwide prospective registry (RIMM) 137
Methods for the analysis of mass spectrometry data in proteomics 135
A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli 135
Evaluation of the T-IDDM Project in Pavia 134
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 133
Improving protein identification by MsPI using peak intensity 132
Ethanol? Whey not! 132
Protein identification by peptide mass fingerprinting: a perl procedure 131
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 131
A Perl procedure for the analysis of phosphopeptide tandem mass spectra 130
Phosphopeptide identification: an automated Perl procedure 130
Movement detection from a wearable system: a deconvolution-based approach 128
OPTIMIZATION OF GAMMA-PGA BIOSYNTHESIS SUPPORTED BY SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING STRATEGIES 128
A Bayesian nonparametric approach to AUC determination in population studies 127
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 126
A tumor growth inhibition model in drugs combination regimens 125
Learning Gene Regulatory Networks with an Intelligent Data Analysis Approach: An Application to the Yeast Cell Cycle 124
A mathematical model for assessing the glucose time course in critically ill patients 124
In-Silico and in-Vivo Metabolic Engineering Strategies to Optimize Waste Bioconversion Pathways in Microbial Strains: Two Case Studies on Ethanol and Poly-Gamma-Glutamic Acid Biosynthesis 124
A bioinformatic approach to predict the cross-kingdompotential of plant miRNA in humans 123
A Perl procedure for protein identification by Peptide Mass Fingerprinting 122
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 122
A procedure to decompose high resolution mass spectra 122
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 121
A Perl procedure to improve the efficiency of the identification and characterization of phosphopeptides 121
A BioBrick-compatible Vector for Allelic Replacement Using the XylE Gene as Selection Marker 121
Integrative analysis of heterogeneous high-throughput transcriptomic data for promoter selection in bacterial genomes to support microbial synthetic biology 120
Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices 120
A methodology for the reliable analysis of amplicon-based NGS data 120
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 119
A Bioinformatics Approach to Explore MicroRNAs as Tools to Bridge Pathways Between Plants and Animals. Is DNA Damage Response (DDR) a Potential Target Process? 119
Integration of enzymatic data in Bacillus subtilis genome-scale metabolic model improves phenotype predictions and enables in silico design of poly-γ-glutamic acid production strains 119
Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release 118
Analisi di dati di DNA microarray: reti di regolazione 118
Optimization of γ-PGA biosynthesis supported by synthetic biology and metabolic engineering strategies 118
Precedence Temporal Networks from Gene Expression Data 117
A mathematical model to study the effects of drugs administration on tumor growth dynamics 117
Analisi di dati di DNA microarray: fondamenti, selezione di geni, classificazione 116
Biologia sintetica e standardizzazione: verso la programmazione razionale di funzioni biologiche artificiali 116
Analysis of intergenic conserved sequences in the POF critical region on X chromosome 114
Modeling myelosuppression in patients treated with anticancer drugs 114
'Indolent' myelofibrosis with myeloid metaplasia: specific clinical features and prognosis 114
Conversion of industrial bio-waste into biofuels through Syntetic Biology supported by flow cytometry 114
Learning Rules with Complex Temporal Patterns in Biomedical Domains 112
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 111
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 111
Genome-wide gene expression in aneurysmal aortic walls of patients with Marfan Syndrome (MFS) and Loeys-Dietz Syndromes (LDS) with known causative mutations 111
Characterization of promoter strength varying the DNA copy number from one to hundreds of copy 111
Engineering signal processing pathways in living cells: from logic gates to logic funtions 110
Bottom-up design of genetic circuits: characterization and re-use of biological building blocks to engineer predictable systems 110
Online Microreactor Titanium Dioxide RPLC-LTQ-Orbitrap MS Automated Platform for Shotgun Analysis of (Phospho) Proteins in Human Amniotic Fluid 110
Design and implementation of a negative feedback controller in E. coli with a bottom-up approach 110
Methods for genetic optimization of biocatalysts for biofuel production from dairy waste through synthetic biology 110
Three thiamine analogues differently alter thiamine transport and metabolism in nervous tissues: an in vivo kinetic study using rats 110
Predicting Aqueous and Intrinsic Solubility of Pharmaceutical Molecules with Neural Networks 109
Precedence Temporal Networks: a New Tool for Extracting Temporal Relationships in Gene Expression Profiles 108
MsPI: A software tool for protein identification by PMF 108
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 108
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 108
Optimal age and strategy for screening hereditary hemochromatosis. The answers from a Markov decision process 107
Heart rate correction of the QT interval: a nonparametric individualized approach 107
Characterization of a synthetic luxR-HSL repressible promoter for the design of novel activation-repression circuits in E. coli 107
Modeling the effects of promoter and regulator copy number variation on the output of inducible systems in engineered genetic circuits 107
Tumor growth modelling for drug development 107
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 107
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 107
CTRL + E.: Signalling is Nothing Without Control 106
Accurate peak list extraction from proteomic mass spectra for identification and profiling studies 106
BioBrick, standard assembly e registro delle parti biologiche standard 105
Characterization of promoter strength at different DNA copy numbers using RPUs 105
Methods and tools for multiscale modelling in Systems Pharmacology: a review 105
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 105
Clustering bayesiano di serie temporali di espressione genica 104
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 104
Efficient phosphopeptide identification from tandem mass spectra 104
A new approach for the analysis of mass spectrometry data for biomarker discovery 104
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 103
Bayesian clustering of gene expression time series 103
A mininal model of tumor growth inhibition 103
Identification of phosphorylated peptides by MS/MS 103
Steps towards the design of complex quorum sensing networks through standard biological parts: characterization of a synthetic LuxR-HSL repressible promoter 103
Characterization of promoter strength at different DNA copy numbers using RPU approach 103
Characterization of an inducible promoter in different DNA copy number conditions 103
Studying the effects of cell-to-cell viariability on the quantitative behaviour of synthetic biological networks through stochastic simulations 103
Engineering endogenous fermentative routes in ethanologenic Escherichia coli W for bioethanol production from concentrated whey permeate 103
Totale 12.094
Categoria #
all - tutte 139.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.103 0 0 0 0 0 0 25 325 121 316 240 76
2021/20221.798 46 25 91 26 23 39 52 126 95 48 297 930
2022/20235.952 651 527 83 416 567 520 17 328 2.564 36 137 106
2023/20242.397 227 459 106 163 169 505 133 171 31 64 115 254
2024/20256.165 122 590 193 202 219 225 260 412 1.536 198 707 1.501
2025/20269.957 1.263 1.168 1.866 1.775 1.959 664 1.262 0 0 0 0 0
Totale 35.815